Biotechnology company CardiAI has announced the worldwide introduction and distribution of BPAro, a new 24-hour Ambulatory Blood Pressure Monitoring (ABPM) system.

The compact, portable, self-monitoring blood pressure device includes Bluetooth for the wireless collection of data, which is uploaded to a secure cloud database.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

It is clinically validated for accuracy and has already received approvals from the US Food and Drug Administration (FDA) and Health Canada.

The German-manufactured device can serve as a diagnostic foundation by constantly monitoring human blood pressure and automatically recording patient blood pressure at regular intervals for up to 30 hours.

It has been designed and tested to be user-friendly and has simple instructions for patients and doctors.

The new ABPM device can collect blood pressure measurements at 30-minute intervals for up to seven days.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

CardiAI founder and CEO Dr Anmol Kapoor said: “BPAro is the first to release among a number of point-of-care devices that will bridge the gap between a patient’s everyday life and the doctor’s office to aid in better patient treatment and preventative healthcare solutions.”

“High blood pressure can be a serious condition that could lead to heart attacks, strokes, kidney failure and loss of vision.

“Accurate and long-term blood pressure metrics aid in patient diagnosis and treatment. BPAro removes uncertainty and puts precision medicine in your hands.”

The device wirelessly uploads data to the BPAro app, and the data generated is used to create a blood pressure profile for each patient in a personal cloud account.

By synchronising the patient and physician results in real-time, the device provides blood pressure monitoring for evidence-based healthcare records.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
SC MEDICA’s minimally invasive, radiation free spinal facet fixation system, FFX® is transforming spinal pain management and improving outcomes for surgeons and patients alike. Learn how SC MEDICA’s award-winning technology is redefining standards in facet joint pain treatment.

Discover the Impact